About 454
News
Find a list of 454 Life Sciences™'s press releases below:
Current | 2006 | 2005 | 2004 | 2003 | 2002
This part of our web site contains archival information, which should not be considered current and may no longer be accurate.
- 12/20/2004
Study on First New Potential Drug for Tuberculosis in 40 Years Aided by
-- Routine whole genome sequencing ushers in a new age of medicine -- - 10/14/2004
454 Life Sciences Receives $5 million NIH Grant for
Award recognizes the potential of 454 Life Sciences' technology to routinely sequence individual human genomes - 5/19/2004
454 Life Sciences Receives $2.4 million NIH Grant for Next Generation Whole Genome Picoliter-Scale Sequencing Technology
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation (Nasdaq: CRGN), today announced that the Company has received a two-year, $2.4 million grant from the National Human Genome Research Institute (NHGRI).